US judge overturns Eli Lilly's $176.5 million loss in Teva patent case
By Blake Brittain Drugmaker Eli Lilly convinced a federal judge in Massachusetts on Tuesday to overturn a $176.5
2023-09-27 05:24
Teva agrees to pay $126 million to US hospitals over opioids
By Brendan Pierson Teva Pharmaceutical Industries Ltd has agreed to pay up to $126 million to U.S. hospitals
2023-08-04 00:53
Private Equity Backers of Plan B Morning-After Pill Weigh $4 Billion Sale of Company
The private equity owners of Foundation Consumer Healthcare are exploring a potential sale of the company behind popular
2023-07-27 02:16
Roivant Attracts Interest for $7 Billion-Plus Bowel Drug
Roivant Sciences Ltd. is attracting interest from large pharmaceutical companies for its treatment for inflammatory bowel disease, which
2023-07-07 03:21
Teva to pay Nevada $193 million over role in opioid epidemic
By Brendan Pierson Teva Pharmaceutical Industries on Wednesday agreed to pay Nevada $193 million to settle claims that
2023-06-08 05:25
Three chemical giants agree to pay more than $1 billion to settle 'forever chemical' claims
The companies Chemours, DuPont and Corteva announced on Friday they have agreed to pay more than $1 billion to settle claims that "forever chemicals" contaminated public US water systems.
2023-06-03 23:25